Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis

Sjögren's syndrome (SS) is a chronic autoimmune disease characterized by salivary and lacrimal gland dysfunction. Clinical observations and results from animal models of SS support the role of aberrant epithelial cell apoptosis and immune homeostasis loss in the glands as triggering factors for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2014
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00099104_v177_n3_p662_Hauk
http://hdl.handle.net/20.500.12110/paper_00099104_v177_n3_p662_Hauk
Aporte de:
id paper:paper_00099104_v177_n3_p662_Hauk
record_format dspace
spelling paper:paper_00099104_v177_n3_p662_Hauk2023-06-08T14:34:08Z Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis Apoptotic cell clearance Monocytes Sjögren's syndrome patients VPAC receptors hydroxychloroquine levothyroxine lipopolysaccharide pilocarpine prednisone vasoactive intestinal polypeptide receptor 1 vasoactive intestinal polypeptide receptor 2 adult aged apoptosis article cell function cell isolation cell phagocytosis clinical article controlled study epithelium cell female human human cell immunomodulation macrophage monocyte priority journal protein expression protein function Sjoegren syndrome systemic therapy apoptotic cell clearance monocytes Sjögren's syndrome patients VPAC receptors Adult Aged Apoptosis Case-Control Studies Cytophagocytosis Gene Expression Regulation Humans Lipopolysaccharides Middle Aged Monocytes Receptors, Vasoactive Intestinal Peptide Receptors, Vasoactive Intestinal Peptide, Type II Sjogren's Syndrome Vasoactive Intestinal Peptide Young Adult Sjögren's syndrome (SS) is a chronic autoimmune disease characterized by salivary and lacrimal gland dysfunction. Clinical observations and results from animal models of SS support the role of aberrant epithelial cell apoptosis and immune homeostasis loss in the glands as triggering factors for the autoimmune response. Vasoactive intestinal peptide (VIP) promotes potent anti-inflammatory effects in several inflammatory and autoimmune disease models, including the non-obese diabetic (NOD) mouse model of SS. With the knowledge that VIP modulates monocyte function through vasoactive intestinal peptide receptors (VPAC) and that immune homeostasis maintenance depends strongly upon a rapid and immunosuppressant apoptotic cell clearance by monocytes/macrophages, in this study we explored VPAC expression on monocytes from primary SS (pSS) patients and the ability of VIP to modulate apoptotic cell phagocytic function and cytokine profile. Monocytes isolated from individual pSS patients showed an increased expression of VPAC2 subtype of VIP receptors, absent in monocytes from control subjects, with no changes in VPAC1 expression. VPAC2 receptor expression could be induced further with lipopolysaccharide (LPS) in pSS monocytes and VIP inhibited the effect. Moreover, monocytes from pSS patients showed an impaired phagocytosis of apoptotic epithelial cells, as evidenced by reduced engulfment ability and the failure to promote an immunosuppressant cytokine profile. However, VIP neither modulated monocyte/macrophage phagocytic function nor did it reverse their inflammatory profile. We conclude that monocytes from pSS patients express high levels of VPAC2 and display a deficient clearance of apoptotic cells that is not modulated by VIP. © 2014 British Society for Immunology. 2014 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00099104_v177_n3_p662_Hauk http://hdl.handle.net/20.500.12110/paper_00099104_v177_n3_p662_Hauk
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Apoptotic cell clearance
Monocytes
Sjögren's syndrome patients
VPAC receptors
hydroxychloroquine
levothyroxine
lipopolysaccharide
pilocarpine
prednisone
vasoactive intestinal polypeptide receptor 1
vasoactive intestinal polypeptide receptor 2
adult
aged
apoptosis
article
cell function
cell isolation
cell phagocytosis
clinical article
controlled study
epithelium cell
female
human
human cell
immunomodulation
macrophage
monocyte
priority journal
protein expression
protein function
Sjoegren syndrome
systemic therapy
apoptotic cell clearance
monocytes
Sjögren's syndrome patients
VPAC receptors
Adult
Aged
Apoptosis
Case-Control Studies
Cytophagocytosis
Gene Expression Regulation
Humans
Lipopolysaccharides
Middle Aged
Monocytes
Receptors, Vasoactive Intestinal Peptide
Receptors, Vasoactive Intestinal Peptide, Type II
Sjogren's Syndrome
Vasoactive Intestinal Peptide
Young Adult
spellingShingle Apoptotic cell clearance
Monocytes
Sjögren's syndrome patients
VPAC receptors
hydroxychloroquine
levothyroxine
lipopolysaccharide
pilocarpine
prednisone
vasoactive intestinal polypeptide receptor 1
vasoactive intestinal polypeptide receptor 2
adult
aged
apoptosis
article
cell function
cell isolation
cell phagocytosis
clinical article
controlled study
epithelium cell
female
human
human cell
immunomodulation
macrophage
monocyte
priority journal
protein expression
protein function
Sjoegren syndrome
systemic therapy
apoptotic cell clearance
monocytes
Sjögren's syndrome patients
VPAC receptors
Adult
Aged
Apoptosis
Case-Control Studies
Cytophagocytosis
Gene Expression Regulation
Humans
Lipopolysaccharides
Middle Aged
Monocytes
Receptors, Vasoactive Intestinal Peptide
Receptors, Vasoactive Intestinal Peptide, Type II
Sjogren's Syndrome
Vasoactive Intestinal Peptide
Young Adult
Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis
topic_facet Apoptotic cell clearance
Monocytes
Sjögren's syndrome patients
VPAC receptors
hydroxychloroquine
levothyroxine
lipopolysaccharide
pilocarpine
prednisone
vasoactive intestinal polypeptide receptor 1
vasoactive intestinal polypeptide receptor 2
adult
aged
apoptosis
article
cell function
cell isolation
cell phagocytosis
clinical article
controlled study
epithelium cell
female
human
human cell
immunomodulation
macrophage
monocyte
priority journal
protein expression
protein function
Sjoegren syndrome
systemic therapy
apoptotic cell clearance
monocytes
Sjögren's syndrome patients
VPAC receptors
Adult
Aged
Apoptosis
Case-Control Studies
Cytophagocytosis
Gene Expression Regulation
Humans
Lipopolysaccharides
Middle Aged
Monocytes
Receptors, Vasoactive Intestinal Peptide
Receptors, Vasoactive Intestinal Peptide, Type II
Sjogren's Syndrome
Vasoactive Intestinal Peptide
Young Adult
description Sjögren's syndrome (SS) is a chronic autoimmune disease characterized by salivary and lacrimal gland dysfunction. Clinical observations and results from animal models of SS support the role of aberrant epithelial cell apoptosis and immune homeostasis loss in the glands as triggering factors for the autoimmune response. Vasoactive intestinal peptide (VIP) promotes potent anti-inflammatory effects in several inflammatory and autoimmune disease models, including the non-obese diabetic (NOD) mouse model of SS. With the knowledge that VIP modulates monocyte function through vasoactive intestinal peptide receptors (VPAC) and that immune homeostasis maintenance depends strongly upon a rapid and immunosuppressant apoptotic cell clearance by monocytes/macrophages, in this study we explored VPAC expression on monocytes from primary SS (pSS) patients and the ability of VIP to modulate apoptotic cell phagocytic function and cytokine profile. Monocytes isolated from individual pSS patients showed an increased expression of VPAC2 subtype of VIP receptors, absent in monocytes from control subjects, with no changes in VPAC1 expression. VPAC2 receptor expression could be induced further with lipopolysaccharide (LPS) in pSS monocytes and VIP inhibited the effect. Moreover, monocytes from pSS patients showed an impaired phagocytosis of apoptotic epithelial cells, as evidenced by reduced engulfment ability and the failure to promote an immunosuppressant cytokine profile. However, VIP neither modulated monocyte/macrophage phagocytic function nor did it reverse their inflammatory profile. We conclude that monocytes from pSS patients express high levels of VPAC2 and display a deficient clearance of apoptotic cells that is not modulated by VIP. © 2014 British Society for Immunology.
title Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis
title_short Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis
title_full Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis
title_fullStr Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis
title_full_unstemmed Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis
title_sort monocytes from sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis
publishDate 2014
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00099104_v177_n3_p662_Hauk
http://hdl.handle.net/20.500.12110/paper_00099104_v177_n3_p662_Hauk
_version_ 1768543685276860416